🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Windward Bio Group AG (WWB)
null: WWB · Real-Time Price · USD
24.01
+1.37 (6.05%)
Nov 19, 2026, 4:00 PM EST - Market closed

Windward Bio Group AG Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Selling, General & Admin
23.8319.242.21
Research & Development
49.432.590.17
Operating Expenses
73.2351.832.38
Operating Income
-73.23-51.83-2.38
Interest Expense
-0.01-0.01-
Interest & Investment Income
0.230.2-
Currency Exchange Gain (Loss)
-0.06-0.03-
EBT Excluding Unusual Items
-73.06-51.67-2.38
Gain (Loss) on Sale of Investments
4.863.39-
Pretax Income
-68.21-48.28-2.38
Income Tax Expense
00.05-
Net Income
-68.21-48.32-2.38
Net Income to Common
-68.21-48.32-2.38
Net Income Growth
---
Shares Outstanding (Basic)
8610
Shares Outstanding (Diluted)
8610
Shares Change
--35.05%-
EPS (Basic)
-8.85-7.44-0.24
EPS (Diluted)
-8.85-7.44-0.24
EPS Growth
---

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Free Cash Flow
-49.98-33.79-0.15
Free Cash Flow Per Share
-6.48-5.20-0.01
EBITDA
-73.09-51.78-
D&A For EBITDA
0.130.05-
EBIT
-73.23-51.83-2.38
SEC Filings: 10-K · 10-Q